Transitioning From Detoxification to Substance Use Disorder Treatment: Facilitators and Barriers

被引:38
|
作者
Timko, Christine [1 ,2 ]
Schultz, Nicole R. [3 ]
Britt, Jessica [1 ,4 ]
Cucciare, Michael A. [5 ,6 ,7 ]
机构
[1] Palo Alto Hlth Care Syst, Dept Vet Affairs, Ctr Innovat Implementat Ci2i, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[3] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA
[4] Stanford Univ Consortium, Pacific Grad Sch Psychol, Clin Psychol Grad Program, Palo Alto, CA 94304 USA
[5] Cent Arkansas Vet Affairs Healthcare Syst, Ctr Mental Healthcare & Outcomes Res, North Little Rock, AR 72205 USA
[6] Cent Arkansas Vet Healthcare Syst, Vet Affairs South Cent VISN Mental Illness Res Ed, North Little Rock, AR 72205 USA
[7] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA
关键词
Detoxification; Addiction; Treatment; Qualitative; Care transitions; Providers; DRUG-ABUSE TREATMENT; TREATMENT ENTRY; PRIMARY-CARE; INPATIENT DETOXIFICATION; CASE-MANAGEMENT; ALCOHOL DETOXIFICATION; TREATMENT-SEEKING; MENTAL-HEALTH; OUTCOMES; INTERVENTIONS;
D O I
10.1016/j.jsat.2016.07.010
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Although successful transitions from detoxification to substance use disorder treatment are associated with improved outcomes, many detoxification patients do not initiate treatment This qualitative study informs detoxification and addiction treatment providers, and health systems, about how to improve detoxification to treatment transitions, by reporting detoxification providers' views of transition facilitators and barriers. The sample consisted of 30 providers from 30 Veterans Health Administration detoxification programs. Themes regarding transition facilitators and barriers emerged at the patient, program (detoxification programs, and addiction programs), and system levels. Detoxification program-level practices of discharge planning, patient education, and rapport building were reported as facilitating the transition to treatment. Six themes captured transition facilitators within addiction treatment programs: the provision of evidence-based practices, patient-centered care, care coordination, aftercare, convenience, and a well-trained and professional staff. This study expands previous literature on detoxification and addiction treatment by systematically and qualitatively examining factors that promote and hinder treatment initiation after inpatient and outpatient detoxification, from a provider perspective, in an era of health care reform and expanded substance use disorder treatment. Published by Elsevier Inc.
引用
收藏
页码:64 / 72
页数:9
相关论文
共 50 条
  • [41] Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?
    Makarenko, Iuliia
    Artenie, Adelina
    Hoj, Stine
    Minoyan, Nanor
    Jacka, Brendan
    Zang, Geng
    Barlett, Gillian
    Jutras-Aswad, Didier
    Martel-Laferriere, Valerie
    Bruneau, Julie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 72 : 69 - 76
  • [42] Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership
    Burke, Kathryn N.
    Krawczyk, Noa
    Li, Yuzhong
    Byrne, Lauren
    Desai, Isha K.
    Bandara, Sachini
    Feder, Kenneth A.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 162
  • [43] Barriers and facilitators to successful transition from long-term residential substance abuse treatment
    Manuel, Jennifer I.
    Yuan, Yeqing
    Herman, Daniel B.
    Svikis, Dace S.
    Nichols, Obie
    Palmer, Erin
    Deren, Sherry
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 74 : 16 - 22
  • [44] Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
    Alcala Partera, J. A.
    Fontalba Navas, A.
    Company Morales, M.
    Romero Guillena, S. L.
    Gutierrez Higueras, T.
    Calera Cortes, F.
    Vicent Fores, S.
    Gutierrez Rojas, L.
    EUROPEAN PSYCHIATRY, 2021, 64 : S196 - S196
  • [45] Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use
    Jacobson, Nora
    Horst, Julie
    Wilcox-Warren, Liam
    Toy, Alex
    Knudsen, Hannah K.
    Brown, Randy
    Haram, Eric
    Madden, Lynn
    Molfenter, Todd
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2020, 47 (04): : 439 - 448
  • [46] Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use
    Nora Jacobson
    Julie Horst
    Liam Wilcox-Warren
    Alex Toy
    Hannah K. Knudsen
    Randy Brown
    Eric Haram
    Lynn Madden
    Todd Molfenter
    The Journal of Behavioral Health Services & Research, 2020, 47 : 439 - 448
  • [47] Assessing barriers to meditation in patients with substance use disorder
    Champagne-Langabeer, Tiffany
    Cohen, A. Sarah
    Lopez, Audrey
    Bakos-Block, Christine
    Campbell, Alisha
    Gopal, Bhanumathi
    Cardenas-Turanzas, Marylou
    Poudel, Ashmita
    Ratcliff, Chelsea
    Malik, Aila
    Korupolu, Radha
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2025, 59
  • [48] Eligible Prescriber Experiences with Substance Use Disorder Treatment and Perceptions of Pharmacy Barriers to Buprenorphine
    Harless, J. Chase
    Hughes, Phillip M.
    Wilson, Courtenay
    Carpenter, Delesha
    Ostrach, Bayla
    SOUTHERN MEDICAL JOURNAL, 2022, 115 (08) : 584 - 592
  • [49] Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field
    Ashford, Robert D.
    Brown, Austin M.
    Curtis, Brenda
    DRUG AND ALCOHOL DEPENDENCE, 2018, 189 : 62 - 69
  • [50] Facilitators and Barriers to Participating in a Randomized Controlled Trial of a Psychological Therapy for Substance Use
    Thong, Ivan Shin Kai
    Ulph, Fiona
    Barrowclough, Christine
    Gregg, Lynsey
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2019, 207 (06) : 487 - 496